For the Inventor, By the Inventor

Enter assignee name

Nagoya University

USPTO Granted Patents = 371

% Expired Patents = 42.3

CIPO Patents = 3

EPO Patents = 110

Forward Citations = 1,858

Loading Chart...

Loading Chart...

904 inventors (with patents filed for the assignee):

Hiroaki Takada (23 out of 28 patents)

Masaru Hori (18 out of 53 patents)

Ryo Kurachi (18 out of 21 patents)

4. Kazuaki Ishihara (12 out of 12 patents)

5. Tsukasa Torimoto (11 out of 33 patents)

6. Makoto Sawada (10 out of 33 patents)

7. Toru Ujihara (10 out of 11 patents)

8. Hitoshi Hirata (9 out of 12 patents)

9. Nagahiro Saito (9 out of 10 patents)

10. Eiji Shamoto (9 out of 17 patents)

11. Nahoko Baileykobayashi (8 out of 30 patents)

12. Tetsuhiko Yoshida (8 out of 58 patents)

13. Norikazu Suzuki (8 out of 8 patents)

14. Yukihiro Miyashita (8 out of 20 patents)

15. Osamu Takai (8 out of 9 patents)

Core Competencies:

Stem Cell Differentiation

Cancer Detection

Antitumor Peptides

Cardiovascular Disease

AlN Crystals

Silicon Carbide

Proton-Conductive Membrane

Laser Therapeutic Device

Semiconductor Nanoparticles

Grafted Seedlings

Medical Treatment Tools

371 patents: Sort by Forward Citations

1. 12378518 - Differentiation induction from human pluripotent stem cells into hypothalamic neurons (2025-08-05),

2. 12365823 - AlN crystal preparation method, AlN crystals, and organic compound including AlN crystals (2025-07-22),

3. 12009206 - Vapor phase epitaxial growth device (2024-06-11),

4. 11965011 - Antitumor peptide and use thereof (2024-04-23),

5. 11939267 - Method and apparatus for producing AlN whiskers, AlN whisker bodies, AlN whiskers, resin molded body, and method for producing resin molded body (2024-03-26),

6. 11883438 - Sperm activator and uses thereof (2024-01-30),

7. 11834695 - Marker and method for determination of Parkinson's disease (2023-12-05),

8. 11787126 - Bonding system and bonding method (2023-10-17),

9. 11733673 - Numerical control system and motor drive controller (2023-08-22),

10. 11651859 - Method for predicting severity and prognosis of cardiovascular disease (2023-05-16),

11. 11630437 - Numerical control system and motor drive controller (2023-04-18),

12. 11606213 - On-vehicle authentication system, communication device, on-vehicle authentication device, communication device authentication method and communication device manufacturing method (2023-03-14),

13. 11591717 - Vapor phase epitaxial growth device (2023-02-28),

14. 11576713 - Medical treatment tool (2023-02-14),

15. 11505589 - Antitumor peptide and use thereof (2022-11-22),

Company Overview

Nagoya University, located in Nagoya, Japan, is a leading institution in biomedical engineering, focusing on advanced research and development in various health-related technologies. The university specializes in areas such as stem cell differentiation, cancer detection, and the development of antitumor peptides, contributing significantly to the understanding and treatment of cardiovascular diseases. Additionally, it explores innovative materials like AlN crystals and silicon carbide, alongside cutting-edge devices such as laser therapeutic systems and proton-conductive membranes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

371 Patents

#7 in Nagoya

#462 in Japan

#2,488 in the World

Nagoya University

Forward Citations = 1,858

904 inventors:

Hiroaki Takada (23 out of 28 patents)

Masaru Hori (18 out of 53 patents)

Ryo Kurachi (18 out of 21 patents)

4. Kazuaki Ishihara (12 out of 12 patents)

5. Tsukasa Torimoto (11 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nagoya University. Retrieved from https://idiyas.com/company/nagoya-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…